
Alcon looks ready to shake up the retinal treatment device market with the launch of the Unity VCS later in 2025. Anytime the world’s number one manufacturer of vitreoretinal surgical systems introduces a new machine, it is bound to make waves. Alcon has a large pool of users, which is reflected by market revenue shares. Those users might be open to upgrading. Some features of the Unity VCS make a strong case for doing so. The Unity VCS catches up with advances introduced by competitors’ syst...
Purchasing one of the following products will open up access to this article's content, which is also available in each comprehensive report/subscription.